Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollution | 6 | 2025 | 316 | 1.790 |
Why?
|
| Particulate Matter | 5 | 2025 | 315 | 1.260 |
Why?
|
| Venous Thromboembolism | 2 | 2023 | 316 | 0.770 |
Why?
|
| Disease Susceptibility | 1 | 2023 | 347 | 0.700 |
Why?
|
| Brain Ischemia | 1 | 2023 | 338 | 0.640 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 1289 | 0.580 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 1040 | 0.540 |
Why?
|
| Models, Statistical | 1 | 2021 | 669 | 0.530 |
Why?
|
| Air Pollutants | 5 | 2025 | 430 | 0.520 |
Why?
|
| Medicare | 5 | 2024 | 773 | 0.490 |
Why?
|
| Stroke | 2 | 2023 | 1120 | 0.470 |
Why?
|
| Research Design | 1 | 2021 | 1139 | 0.450 |
Why?
|
| Environmental Exposure | 4 | 2024 | 579 | 0.370 |
Why?
|
| Heart Failure | 1 | 2023 | 2236 | 0.330 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 2 | 2019 | 22 | 0.290 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2025 | 1040 | 0.270 |
Why?
|
| United States | 11 | 2025 | 14841 | 0.250 |
Why?
|
| Aged | 12 | 2025 | 23961 | 0.230 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 47 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 2531 | 0.200 |
Why?
|
| Hypnotics and Sedatives | 1 | 2025 | 200 | 0.200 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2019 | 480 | 0.200 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 65 | 0.200 |
Why?
|
| Environmental Monitoring | 1 | 2025 | 370 | 0.200 |
Why?
|
| Biguanides | 1 | 2022 | 12 | 0.190 |
Why?
|
| Selection Bias | 1 | 2022 | 37 | 0.190 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2025 | 165 | 0.190 |
Why?
|
| Pharmacists | 1 | 2025 | 265 | 0.190 |
Why?
|
| Calibration | 1 | 2022 | 146 | 0.190 |
Why?
|
| Poverty | 2 | 2023 | 521 | 0.190 |
Why?
|
| Causality | 1 | 2022 | 126 | 0.190 |
Why?
|
| Coronary Artery Disease | 2 | 2019 | 698 | 0.180 |
Why?
|
| Entropy | 1 | 2021 | 41 | 0.180 |
Why?
|
| Temperature | 1 | 2024 | 679 | 0.170 |
Why?
|
| Social Class | 1 | 2023 | 282 | 0.170 |
Why?
|
| Food Assistance | 1 | 2021 | 30 | 0.170 |
Why?
|
| Probability | 1 | 2021 | 304 | 0.170 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 258 | 0.170 |
Why?
|
| Coronary Angiography | 2 | 2019 | 317 | 0.170 |
Why?
|
| Humans | 21 | 2025 | 137585 | 0.160 |
Why?
|
| Fruit | 1 | 2021 | 140 | 0.160 |
Why?
|
| Hospitalization | 3 | 2025 | 2199 | 0.160 |
Why?
|
| Vegetables | 1 | 2021 | 157 | 0.160 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2023 | 565 | 0.160 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 266 | 0.160 |
Why?
|
| Machine Learning | 2 | 2022 | 493 | 0.160 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 2111 | 0.150 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2023 | 293 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2024 | 664 | 0.150 |
Why?
|
| Myocardial Infarction | 2 | 2024 | 1046 | 0.150 |
Why?
|
| Hypoglycemia | 1 | 2024 | 445 | 0.150 |
Why?
|
| Myocardial Revascularization | 1 | 2019 | 73 | 0.150 |
Why?
|
| Metformin | 1 | 2022 | 331 | 0.150 |
Why?
|
| Eating | 1 | 2021 | 380 | 0.140 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2025 | 678 | 0.140 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 205 | 0.140 |
Why?
|
| Retrospective Studies | 6 | 2024 | 15657 | 0.130 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2017 | 54 | 0.130 |
Why?
|
| Aspirin | 1 | 2019 | 387 | 0.120 |
Why?
|
| Quality of Life | 2 | 2025 | 2892 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2019 | 415 | 0.110 |
Why?
|
| Pragmatic Clinical Trials as Topic | 2 | 2025 | 65 | 0.110 |
Why?
|
| Diet | 1 | 2021 | 1278 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 2069 | 0.100 |
Why?
|
| Male | 9 | 2025 | 67762 | 0.090 |
Why?
|
| Hot Temperature | 2 | 2024 | 391 | 0.090 |
Why?
|
| Female | 9 | 2025 | 73304 | 0.090 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 7635 | 0.080 |
Why?
|
| Hypoglycemic Agents | 3 | 2024 | 1291 | 0.080 |
Why?
|
| Middle Aged | 7 | 2025 | 33479 | 0.070 |
Why?
|
| Blood Glucose | 3 | 2022 | 2186 | 0.070 |
Why?
|
| Adult | 3 | 2024 | 37929 | 0.060 |
Why?
|
| Taiwan | 1 | 2024 | 31 | 0.050 |
Why?
|
| Melatonin | 1 | 2025 | 150 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2024 | 43 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2024 | 132 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2024 | 5742 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 564 | 0.050 |
Why?
|
| Prevalence | 2 | 2019 | 2734 | 0.040 |
Why?
|
| San Francisco | 1 | 2021 | 52 | 0.040 |
Why?
|
| Los Angeles | 1 | 2021 | 76 | 0.040 |
Why?
|
| Life Style | 1 | 2023 | 490 | 0.040 |
Why?
|
| Urban Health | 1 | 2021 | 92 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 1266 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2024 | 722 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2019 | 38 | 0.040 |
Why?
|
| Incidence | 1 | 2025 | 2804 | 0.040 |
Why?
|
| Weight Loss | 1 | 2023 | 787 | 0.040 |
Why?
|
| No-Reflow Phenomenon | 1 | 2017 | 7 | 0.030 |
Why?
|
| Disease Progression | 1 | 2025 | 2757 | 0.030 |
Why?
|
| Veterans Health | 1 | 2019 | 186 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 1050 | 0.030 |
Why?
|
| Shock, Cardiogenic | 1 | 2017 | 63 | 0.030 |
Why?
|
| Risk | 1 | 2019 | 912 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2017 | 131 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 530 | 0.030 |
Why?
|
| Risk Factors | 2 | 2022 | 10388 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1477 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 463 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 889 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2021 | 10811 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1070 | 0.030 |
Why?
|
| Insulin | 1 | 2024 | 2409 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2017 | 911 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2019 | 475 | 0.020 |
Why?
|
| Logistic Models | 1 | 2017 | 2074 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2992 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 3295 | 0.020 |
Why?
|
| Registries | 1 | 2017 | 2035 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3457 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 6828 | 0.020 |
Why?
|